GRIN2A and pneumocystosis: Although the chronic administrations of PCP did not modulate GluN2A-NMDAR protein levels in the cortex (Figure 3B: p = 0.8194 compared with control mice), the daily treatment with NX210c for 3 days induced a two-fold increase in the protein levels of GluN2A-NMDAR of PCP mice (Figure 3B: +96.3% compared with control mice; p = 0.0048 and p = 0.0279 compared with vehicle-treated PCP mice and control mice, respectively).